Exodus Point Capital Management, LP Summit Therapeutics Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$1.32 - $2.81 $34,023 - $72,427	25,775 New	25,775 $65,000
Q2 2021 Aug 16, 2021	SELL	$5.15 - $8.46 $481,694 - $791,289	-93,533 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.17 - $11.19 $477,247 - $1.03 Million	-92,311 Reduced 49.67%	93,533 $549,000
Q4 2020 Feb 16, 2021	BUY	$3.25 - $6.0 $603,993 - $1.12 Million	185,844 New	185,844 $873,000

193

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.82B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.